Ifp Advisors, Inc Unity Biotechnology, Inc. Transaction History

Ifp Advisors, Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 06, 2021	SELL	$2.91 - $4.5 $0 - $0	0 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$4.15 - $6.3 $0 - $0	0 New	0 $0
Q1 2021 Apr 30, 2021	BUY	$5.51 - $9.42 $0 - $0	0 New	0 $0
Q4 2020 Jan 25, 2021	BUY	$3.42 - $6.36 $0 - $0	0 New	0 $0
Q3 2020 Oct 29, 2020	SELL	$2.94 - $12.43 $882 - $3,729	-300 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$7.65 - $16.66 $1,530 - $3,332	-200 Reduced 40.0%	300 $2,000
Q3 2018 Oct 25, 2018	BUY	$14.34 - $22.97 $2,868 - $4,594	200 Added 66.67%	500 $0
Q1 2016 Jun 03, 2019	BUY	N/A	300	300 $2,000

4.41M

Ticker UBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,036,200
Market Cap $14M
Description
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.